Medplus Health Services Ltd. (MEDPLUS) Health Services 52 Week Low Streak Extends to Sixth Straight Session

Medplus Health Services 52 Week Low Streak has now run for its sixth consecutive session, with the stock trading within 2% of its 52-week low across the streak. The cumulative move over that period is -4.61%. At 9:23 AM IST, the share price was Rs 596, after touching a low of Rs 596 and a high of Rs 598.4 in the current session. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued weakness.

The stock last traded below its previous close of Rs 599, after opening at Rs 597.95. In market-cap terms, Medplus Health Services stood at Rs 7,196.21 crore at the time of this update. For readers tracking the Medplus Health Services Share Price, the key point is not just the one-session decline but the persistence of the move across multiple trading days. A single-day slide can reflect intraday trading, while a repeated near-52-week-low pattern often keeps the stock on watch because it signals sustained pressure around a yearly low zone.

Medplus Health Services 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 596
Previous Close	Rs 599
Today's Move	Rs -3 (-0.5%)
Open	Rs 597.95
High	Rs 598.4
Low	Rs 596
Market Capitalisation	Rs 7,196.21 crore

Medplus Health Services Ltd. (MEDPLUS) traded at Rs 596 versus the previous close of Rs 599, a fall of 0.5%. The stock opened at Rs 597.95, reached a high of Rs 598.4, touched a low of Rs 596.

The Medplus Health Services Share Price Today was under pressure in early trade, with the stock at Rs 596, down Rs 3 or 0.5% from the previous close of Rs 599. The intraday range remained narrow, with the share price moving between Rs 597.95 and Rs 598.4 before touching Rs 596. That places the stock near the lower end of the visible range at the time of this update. The market capitalisation of Medplus Health Services Ltd. (MEDPLUS) was Rs 7,196.21 crore, keeping the company within the same general size bracket as several listed retail peers in this update.

For investors following the Medplus Health Services Share Price Update, the important detail is that the latest move extends a broader decline rather than standing out as a one-off dip. The stock has kept trading close to its 52-week low for several sessions, which makes the current read more about pattern persistence than about one isolated price point. That is why the Medplus Health Services Stock Performance deserves attention alongside the day’s change. The repeated proximity to the yearly low keeps the stock in the “stocks in news today” conversation even without a fresh event beyond the price trend itself.

What the Repeated 52-Week Lows Show

The Medplus Health Services 52 Week Low Streak suggests that the stock has remained under sustained downward pressure across multiple sessions, even though the latest update does not identify a specific company event behind it. The cumulative decline of -4.61% across the streak matters because it shows that the weakness has been building over time, not just appearing in a single morning move. That is the central difference between a one-day stock slip and a back-to-back low pattern.

For market readers, a repeated near-one-year-low pattern is often a sign to watch the stock more closely for further price confirmation, but it should not be read as a forecast by itself. The data confirms the pattern and the trend, not the reason. In search terms, this is exactly the type of case covered by Medplus Health Services Back To Back 52 Week Lows and Medplus Health Services New One Year Low queries, because the focus is the persistence of weakness rather than a fresh trigger.

Medplus Health Services Ltd. (MEDPLUS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 7,196.21 crore
P/E Ratio	34.19x
P/B Ratio	3.6x
ROE	11.93%
ROCE	22.22%
EPS	Rs 17.52
Book Value Per Share	Rs 166.52
Dividend Yield	0%

Medplus Health Services Ltd. (MEDPLUS) fundamental metrics show P/E 34.19x, P/B 3.6x, ROE 11.93%, ROCE 22.22%. These figures provide context only and are not a buy or sell signal.

Medplus Health Services Ltd. has a market capitalisation of Rs 7,196.21 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.19x, P/B at 3.6x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.93% and ROCE of 22.22%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.52, book value per share of Rs 166.52, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 18.22x, median ROE of 11.78%, median ROCE of 16.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Retailing
Industry	Retailing
Benchmark Scope	same industry
Company P/E Ratio	34.19x
Benchmark Median P/E	18.22x
Benchmark Average P/E	53.77x
Benchmark P/E Range	0x to 1,578.34x
Company P/B Ratio	3.6x
Benchmark Median P/B	2.28x
Company ROE	11.93%
Benchmark Median ROE	11.78%
Company ROCE	22.22%
Benchmark Median ROCE	16.71%
Company Market Capitalisation	Rs 7,196.21 crore
Benchmark Median Market Cap	Rs 187.85 crore

Medplus Health Services Ltd. (MEDPLUS) is classified under sector: Retailing and industry: Retailing.

Medplus Health Services Ltd. (MEDPLUS) has a P/E ratio of 34.19x, which is above the benchmark median of 18.22x, a difference of +87.65%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Medplus Health Services Ltd. (MEDPLUS) has a ROE of 11.93%, which is above the benchmark median of 11.78%, a difference of +1.27%. Medplus Health Services Ltd. (MEDPLUS) has a ROCE of 22.22%, which is above the benchmark median of 16.71%, a difference of +32.97%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Aditya Vision Ltd.	AVL	7,222.05	51.96	9.43	18.55	20.82
Ethos Ltd.	ETHOSLTD	6,928.37	66.7	4.56	7.78	13.7
Electronics Mart India Ltd.	EMIL	6,802.36	33	3.89	6.81	11.84
V2 Retail Ltd.	V2RETAIL	6,381.16	35.72	6.76	25.96	38.43
V-Mart Retail Ltd.	VMART	6,207.28	45.11	6.33	14.43	23.56

Medplus Health Services Ltd. (MEDPLUS) has a P/E ratio of 34.19x compared with the displayed peer median of 45.11x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.93% compares with a peer median of 14.43% across the companies shown in the table. ROCE stood at 22.22% versus the displayed peer median of 20.82%, providing a capital-efficiency comparison. Medplus Health Services Ltd. (MEDPLUS) has a market capitalisation of Rs 7,196.21 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.

Why Investors Are Watching

• The Medplus Health Services 52 Week Low Streak has extended to a sixth consecutive session, keeping the stock near its yearly low zone.
• The cumulative move across the streak is -4.61%, which shows the weakness has persisted across multiple sessions.
• The latest update confirms the price pattern, but it does not establish a company-specific cause for the move.
• Valuation stays above the retail industry median, so the Medplus Health Services Fundamental Analysis remains central to the read.
• Peer comparison suggests the stock is not isolated by size, but its pricing backdrop is different from several listed retail peers.

About the Company

Medplus Health Services Ltd. (MEDPLUS) is part of the retailing space and is tracked on both NSE and BSE. The company’s market capitalisation stood at Rs 7,196.21 crore in this update. For a stock moving near a 52-week low, company background matters because investors often want to separate a short-term share price slide from the underlying business profile. That is also why the Medplus Health Services Share Price is best read with valuation and sector context rather than in isolation.

The company’s current financial ratios show a business that is still operating with positive profitability metrics, even as the share price remains weak. Readers searching for Medplus Health Services Company News or Medplus Health Services Stock Performance should monitor how the market continues to price the stock relative to its peers and its own annual trading range.

Frequently Asked Questions

What does Medplus Health Services 52 Week Low Streak mean?

Ans. It means the stock has traded within 2% of its 52-week low for multiple consecutive sessions. In this case, the streak has reached its sixth consecutive session, which highlights repeated weakness near the yearly low zone.

How many sessions has Medplus Health Services traded near its 52-week low?

Ans. Medplus Health Services has traded within 2% of its 52-week low for six consecutive sessions. That extended pattern is the main reason the stock is being tracked closely in this update.

What is the cumulative move across the streak?

Ans. The cumulative move across the streak is -4.61%. This helps show that the weakness has persisted across the full run of sessions rather than appearing in only one trading day.

Does the latest data confirm a company-specific reason?

Ans. No. The latest Univest data confirms the repeated-low price pattern, but it does not establish a company-specific cause for the continued move. Readers should avoid assuming a trigger that is not supported by the numbers provided.

How did Medplus Health Services trade in the latest update?

Ans. The stock was at Rs 596, down Rs 3 or 0.5% from the previous close of Rs 599. It opened at Rs 597.95 and touched a high of Rs 598.4 in the current session.

Is Medplus Health Services inexpensive on valuation?

Ans. Not on the latest Univest figures alone. The stock’s P/E of 34.19 is above the retail industry median, while its P/B of 3.6 is also above the median. That makes valuation an important part of the discussion.

How do the fundamentals compare with peers?

Ans. Medplus has ROE of 11.93% and ROCE of 22.22%, which are respectable within the peer set. However, its valuation is still higher than the industry median, so the stock is not trading as a cheap retail name.

What should investors monitor next in Medplus Health Services 52 Week Low Streak?

Ans. Investors should watch whether the stock continues to trade near its yearly low, whether the cumulative decline deepens, and whether future company updates change the fundamental picture. The current data only confirms the streak, not the reason behind it.

Track Medplus Health Services Ltd. (MEDPLUS) Share Price on Univest

Use Medplus Health Services Ltd. (MEDPLUS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.